- Home
- CTXR vs BRLT Comparison
CTXR vs BRLT Comparison
Compare CTXR & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTXR | BRLT |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 21.0M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CTXR | BRLT |
|---|---|---|
| Price | $0.78 | $1.32 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $6.00 | $1.70 |
| AVG Volume (30 Days) | ★ 555.0K | 45.8K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.38 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $437,483,000.00 |
| Revenue This Year | N/A | $6.72 |
| Revenue Next Year | $147.57 | $4.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.63 |
| 52 Week Low | $0.63 | $1.21 |
| 52 Week High | $2.38 | $3.10 |
Technical Indicators
Market Signals| Indicator | CTXR | BRLT |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 47.55 |
| Support Level | $0.68 | $1.25 |
| Resistance Level | $0.99 | $1.66 |
| Average True Range (ATR) | 0.07 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 44.65 | 70.59 |
Price Performance
Historical ComparisonAbout CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc is an digitally native omnichannel jewelry company selling The company's products include rings, necklaces, earrings, and bracelets. Its collection of premium-quality diamond engagement and wedding rings, gemstone rings, and fine jewelry is conceptualized by in-house design studio. The company operates in one operating and reporting segment, the retail sale of diamonds, gemstones and jewelry.